News
Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...
IMGS-001 is first dual-specific PD-L1/PD-L2 antibody with cytotoxic killing function and is designed to treat the many "immune-excluded" cancers that are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback